Modern principles of treatment of inflammatory diseases of female genital organs

Н. В. Косей

Abstract


Inflammatory disease of female genital organs is one of the most urgent problems of modern gynecology worldwide. The biggest risk for the health has an inflammation of upper genital tract.

Within the clinical forms of inflammatory diseases of the female genitalia lower genital tract is the most important specific infectious vaginitis: bacterial vaginosis, vulvovaginal candidiasis and Trichomonas vaginitis. The paper describes approaches to their diagnosis and treatment.


Keywords


inflammatory diseases of the female genital organs; bacterial vaginosis; vulvovaginal candidiasis; Trichomonas vaginitis

References


Rogers RG Pelvic Inflammatory Disease. N Engl J Med 2006; 355:743-744. August 17, 2006.

Rolfs RT, Galaid EI, Zaidi AA Pelvic inflammatory disease: trends in hospitalizations and office visits, 1979 through 1988. // Am J Obstet Gynecol-1992;166:983–990.

MEDI-Q «Doctors` opinion». Ukraine, 2005.

Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines 2006. // Centers for Disease Control and Prevention.

WHO. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases. – 1999.

. Braz J In vitro activities of antifungal agents alone and in combination against fluconazolesusceptible and resistant strains of Candida dubliniensis. // Infect Dis. – 2012. – Jan-Feb; 16(1): 78-81.

Sweet RL Treatment of acute pelvic inflammatory disease. // Infect Dis Obstet Gynecol. – 2011;2011.

Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N Comparative study of itraconazole and fluconazole therapy in vaginal candidosis. Department of Microbiology and Virology, Department of General and Oncological Gynecology, Military Medical Academy – Sofia. AkushGinekol (Sofiia) – 2004;43(1):20-3.

P itsouni E, Iavazzo C, Falagas ME Itraconazolevs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials. // Am J Obstet Gynecol. 2008 Feb; 198(2):153-60.

M esa LM, Arcaya N, Canas O, Machado Y, Calvo B Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis. // Rev IberoamMicol. 2004 Sep; 21(3): 135-8.

Foxman B The epidemiology of vuivovaginal candidiasis: risk factors. // Am J Public Health 1990; 80: 329-31.

. British Association for Sexual Health and HIV. 2007 National Guideline for the Management of Genital Herpes

C enters for Disease Control and Prevention (CDC). Diseases characterized by genital, anal, or perianal ulcers. In: Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59(RR-12): 18-39.

T yring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections.The Valaciclovir International Study Group.Arch Dermatol. 1998 Feb; 134(2): 185-91.

Tatarchuk TF, Cossey NV Empirical treatment of vaginal infections.– Institute of Pediatrics, Obstetrics and Gynecology, Ukraine, 2012.

Tikhomirovа AL, Sarsaniya SI Modern principles of prevention and treatment of inflammatory diseases of the female reproductive organs in the operational and non-operational gynecology. Guidelines. – M., 2005. – 11 P.

Lysanaya TA Susceptibility testing conditionally pathogenic vaginal seeded women with colpitis to various antimicrobial agents. – 2010.

Kisina VI Urogenital tract infections in women. Clinical features, diagnosis, treatment. – Moscow: «Medical Information Agency», 2005. – 288 p.

Nikonov AP Infections in obstetrics and gynecology. A practical guidelines to diagnosis and antimicrobial chemotherapy // Gynecology. – 2006. – V. 8, № 2.

Stratchounski LS, Belousov YB, Kozlov SN A practical guidelines to anti-infective chemotherapy. – M., 2007.

Adaskevich VP Sexually transmitted infections.– Moscow: Medical Book, 2004. – 416 p

Kalugina LV, Tatarchuk TF Vulvovaginitis in the practice of family doctors: the choice of therapeutic approach.

Tatarchuk TF, Kalugіna LV, Zakharenko NF Optimizing of the vaginal candidiasis treatment as one of the areas of the youthhealth. – PAG, 2008.

Karapetyan TE, Naskhletashvili IV, Tyutyunnik VL Vulvovaginal candidiasis: a modern approach to the problem // Russian Med. Journal. – 2011. – №1. – P. 64-67.

Protocol «Inflammatory diseases of the pelvic organs». Orderof the MOH No. 582 from 15 December, 2005.

Protocol «infections sexually transmitted». Order of the MOH No. 582 from15 December, 2005.


GOST Style Citations


Татарчук Т.Ф., Косей Н.В. Эмпирическая терапия вагинальных инфекций.– Институт Педиатрии, акушерства и гинекологии Украины, 2012.

Тихомиров А.Л., Сарсания С.И. Современные принципы профилактики и лечения воспалительных заболеваний женских половых органов в оперативной и неоперативной гинекологии. Методические рекомендации. – М., 2005. – 11с.

Rogers RG Pelvic Inflammatory Disease. N Engl J Med 2006; 355:743-744. August 17, 2006.

Rolfs RT, Galaid EI, Zaidi AA Pelvic inflammatory disease: trends in hospitalizations and office visits, 1979 through 1988. // Am J Obstet Gynecol-1992;166:983–990.

MEDI-Q «Doctors` opinion». Ukraine, 2005.

Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines 2006. // Centers for Disease Control and Prevention.

WHO. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases. – 1999.

Лисяная Т.А. Определение чувствительности условно патогенной микрофлоры влагалища, высеваемой у женщин с кольпитом к различным антимикробным препаратам. – 2010.

Кисина В.И. Урогенитальные инфекции у женщин. Клиника, диагностика, лечение. – М.: ООО «Медицинское информационное агенство», 2005. – 288 с.

Никонов А.П. Инфекции в акушерстве и гинекологии. Практическое руководство по диагностике и антимикробной химиотерапии // Гинекология. – 2006.– Т. 8, № 2.

Страчунский Л.С., Белоусов Ю.Б., Козлов С.Н. Практическое руководство по антиинфекционной химиотерапии. – М., 2007.

Адаскевич В.П. Инфекции, передаваемые половым путем. – М.: Медицинская Книга, 2004. – 416 с.

Калугина Л.В., Татарчук Т.Ф. Вульвовагинит в практике семейного врача: выбор терапевтического подхода.

Татарчук Т.Ф., Калугіна Л.В., Захаренко Н.Ф. Оптимізаціялікуваннявагінального кандидоза як один з напрямківзбереженняз доров’ямолоді. – ПАГ, 2008.

. Braz J In vitro activities of antifungal agents alone and in combination against fluconazolesusceptible and resistant strains of Candida dubliniensis. // Infect Dis. – 2012. – Jan-Feb; 16(1): 78-81.

Sweet RL Treatment of acute pelvic inflammatory disease. // Infect Dis Obstet Gynecol. – 2011;2011.

Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N Comparative study of itraconazole and fluconazole therapy in vaginal candidosis. Department of Microbiology and Virology, Department of General and Oncological Gynecology, Military Medical Academy – Sofia. AkushGinekol (Sofiia) – 2004;43(1):20-3.

P itsouni E, Iavazzo C, Falagas ME Itraconazolevs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials. // Am J Obstet Gynecol. 2008 Feb; 198(2):153-60.

Карапетян Т.Э., Насхлеташвили И.В., Тютюнник В.Л. Вульвовагинальный кандидоз: современный взгляд на проблему // Рус. мед. журн. – 2011. – № 1. – С. 64-67.

M esa LM, Arcaya N, Canas O, Machado Y, Calvo B Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis. // Rev IberoamMicol. 2004 Sep; 21(3): 135-8.

Foxman B The epidemiology of vuivovaginal candidiasis: risk factors. // Am J Public Health 1990; 80: 329-31.

. British Association for Sexual Health and HIV. 2007 National Guideline for the Management of Genital Herpes

C enters for Disease Control and Prevention (CDC). Diseases characterized by genital, anal, or perianal ulcers. In: Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59(RR-12): 18-39.

T yring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections.The Valaciclovir International Study Group.Arch Dermatol. 1998 Feb; 134(2): 185-91.

Протокол «Запальні захворювання органів малого тазу». Наказ МОЗ України №582 від 15.12.2005 р.

Протокол «Інфекції, щопередаються статевим шляхом». Наказ МОЗ України №582 від 15.12.2005 р.





DOI: https://doi.org/10.18370/2309-4117.2013.9.78-85

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)